Said 2018 reported a very large reduction (SMD 1.92), whereas Forst 2012 found a small gain (SMD + 0.23) ( Supplementary Figure S2 , Supplementary File S1 )
Key takeaways Compounded semaglutide isnt approved by the FDA, so most insurance companies wont pay for it
PubMed Aroda, V.R., Rosenstock, J., Terauchi, Y., Altuntas, Y., Lalic, N.M., Morales Villegas, E.C., et al
, Beverly Hills Rejuvenation Center Clinical Observations For patients who are ready to transition off active treatment, we discuss maintenance dose strategies versus gradual tapering protocols, always based on your individual labs and progress